CUPERTINO, Calif., July 5, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical enterprise centered on epigenetic regulation to produce remedies for acute organ damage and continual liver health conditions, right now announced the appointment of Timothy M. Papp as its Chief Economic Officer. In this new position, Mr. Papp will immediate and oversee […]